UNM Health Sciences Center Approved by the Commission on Cancer of the American College of Surgeons
The Commission on Cancer of the
Established by the
Receiving care at a Commission on Cancer approved cancer program ensures that patients will have access to:
- High quality care close to home;
- Comprehensive care offering a range of state-of-the-art services and equipment;
- A multi-specialty, team approach to coordinate the best treatment options available to cancer patients;
- Information about cancer clinical trials, education and support;
- Lifelong patient follow-up through a cancer registry that collects data on type and stage of cancers and treatment results;
- Ongoing monitoring and improvement of care.
Approval by the Commission on Cancer is given only to those facilities that have voluntarily committed to provide the best in diagnosis and treatment of cancer and to undergo rigorous evaluation processes and review of their performance. In order to maintain approval, facilities with approved cancer programs must undergo an on-site review every three years.
The American Cancer Society estimates that approximately 1,334,100 cases of cancer will be diagnosed in 2003. Slightly more than one-fifth of the country's hospitals have approved cancer programs and more than 80 percent of patients who are newly diagnosed with cancer are treated in those facilities.
The Commission on Cancer is composed of the Fellows of the
Working with the American Cancer Society, the Cancer Liaison Program of the Commission on Cancer is supported by more than 1,500 voluntary Liaison Physicians who support cancer-control initiatives and the cancer program activities locally. The Commission also tracks national, regional and local cancer care patterns and trends through the National Cancer Database, another joint project with the American Cancer Society.
In addition, the Commission sets standards for cancer registry data collection used by all approved cancer programs and conducts national quality management and improvement studies for specific cancer sites. Results of these studies are used by cancer program leadership to monitor and improve patient care.
Contact: Lynn Melton, 272-3322